Nidan Laboratories & Healthcare Ltd Share Price

33
(0.46%)
Jul 23, 2024|03:32:36 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open32.6
  • Day's High33.6
  • 52 Wk High52.4
  • Prev. Close32.85
  • Day's Low32.55
  • 52 Wk Low27
  • Turnover (lac)2.97
  • P/E21.9
  • Face Value10
  • Book Value47.63
  • EPS1.5
  • Mkt. Cap (Cr.)45.87
  • Div. Yield0
No Records Found

Nidan Laboratories & Healthcare Ltd KEY RATIOS

Sector

Healthcare

Open

32.6

Prev. Close

32.85

Turnover(Lac.)

2.97

Day's High

33.6

Day's Low

32.55

52 Week's High

52.4

52 Week's Low

27

Book Value

47.63

Face Value

10

Mkt Cap (₹ Cr.)

45.87

P/E

21.9

EPS

1.5

Divi. Yield

0

Nidan Laboratories & Healthcare Ltd Corporate Action

1 Sep 2023

12:00 AM

AGM

Announcement Date: 01 Sep, 2023

arrow

1 Sep 2023

12:00 AM

BookCloser

arrow

14 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Nidan Laboratories & Healthcare Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Nidan Laboratories & Healthcare Ltd SHAREHOLDING SNAPSHOT

23 Jul, 2024|04:24 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 57.03%

Foreign: 0.00%

Indian: 57.03%

Non-Promoter- 42.96%

Institutions: 0.00%

Non-Institutions: 42.96%

Custodian: 0.00%

Share Price

Nidan Laboratories & Healthcare Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

13.9

13.9

9.9

9.9

Preference Capital

0

0

0

0

Reserves

55.54

52

3.43

1.13

Net Worth

69.44

65.9

13.33

11.03

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019

Revenue

20.79

22.18

20.6

yoy growth (%)

-6.26

7.64

Raw materials

-2.2

-2.54

-1.72

As % of sales

10.62

11.47

8.34

Employee costs

-2.68

-2.85

-2.43

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019

Profit before tax

3.3

0.71

0.22

Depreciation

-3.18

-3.18

-3.23

Tax paid

-0.99

0

0

Working capital

-3.88

6.08

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2019

Growth matrix (%)

Revenue growth

-6.26

7.64

Op profit growth

16.37

-2.65

EBIT growth

51.76

-10.41

Net profit growth

222.19

219.73

View Ratios

No Record found

Nidan Laboratories & Healthcare Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

6,402.15

91.1792,133.61238.80.091,894.6536.28

Max Healthcare Institute Ltd

MAXHEALTH

930.3

131.5390,378.13241.770.16610.1179.02

Fortis Healthcare Ltd

FORTIS

493.25

300.2137,170.3668.330.2307.48120.36

Global Health Ltd

MEDANTA

1,195.7

88.7731,985.9492.240578.65106.09

Narayana Hrudayalaya Ltd

NH

1,254.1

60.425,637.06158.090.32846.3190.04

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Nidan Laboratories & Healthcare Ltd

Management

Register Office

Registrar Office

Executive Director

Edwin Francis Dabre

Executive Director & CFO

Tejal Anil Jayakar

Non Executive Director

Krupesh Deepak Thakur

Independent Director

Nilesh Ghanshyam Bide

Independent Director

Abhinay Shashikant Nerurkar

Independent Director

Karim Hakam Khimani

Company Secretary

Akshay Joshi

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Reports by Nidan Laboratories & Healthcare Ltd

Summary

The Company was originally incorporated as Abhi Diagnostic Imagings Private Limited on December 05, 2000 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Maharashtra. Subsequently, name of the Company changed from Abhi Diagnostic Imagings Private Limited to Nidan Laboratories And Healthcare Private Limited under the Companies Act, 2013 pursuant to a Special Resolution passed by Shareholders at the EGM held on February 26, 2021 and had obtained fresh Certificate of Incorporation dated March 24, 2021 issued by the Registrar of Companies, Maharashtra. Subsequently, Company got converted into a Public Limited Company and name of the Company was changed to Nidan Laboratories And Healthcare Limited and a fresh Certificate of Incorporation consequent upon conversion to Public Limited Company was issued by the Registrar of Companies, Mumbai, Maharashtra, on May 24, 2021. The Company carry on the business of Diagnostic Centre, such as X-Ray, Sonography, 2 D ECHO, PFT, CST, C.T. Scan, MRI etc., Blood Bank, Pathology Laboratories, Dialysis Unit, Intensive Care Unit, Burn & Poisoning Centre and Poly Clinic.Nidan was established as a Proprietary Firm in 1994 by Promoter, Dr. Nitin Vithalrao Throve in the Northern District of Mumbai where diagnostic services was provided under one roof at reliable and affordable price. The Company came into existence in the year 2000. The business was carried out under the sole proprietorship, which was
Read More

Company FAQs

What is the Nidan Laboratories & Healthcare Ltd share price today?

Down Arrow

The Nidan Laboratories & Healthcare Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is Rs.₹33 today.

What is the Market Cap of Nidan Laboratories & Healthcare Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nidan Laboratories & Healthcare Ltd is ₹45.87 Cr. as of 23 Jul ‘24

What is the PE and PB ratio of Nidan Laboratories & Healthcare Ltd?

Down Arrow

The PE and PB ratios of Nidan Laboratories & Healthcare Ltd is 21.9 and 0.69 as of 23 Jul ‘24

What is the 52 Week High and Low of Nidan Laboratories & Healthcare Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Nidan Laboratories & Healthcare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Nidan Laboratories & Healthcare Ltd is ₹27 and ₹52.4 as of 23 Jul ‘24

What is the CAGR of Nidan Laboratories & Healthcare Ltd?

Down Arrow

Nidan Laboratories & Healthcare Ltd's CAGR for 5 Years at N/I%, 3 Years at -34.66%, 1 Year at -24.05%, 6 Month at -8.37%, 3 Month at 10.79% and 1 Month at -3.95%.

What is the shareholding pattern of Nidan Laboratories & Healthcare Ltd?

Down Arrow

The shareholding pattern of Nidan Laboratories & Healthcare Ltd is as follows:
Promoters - 57.04 %
Institutions - 0.00 %
Public - 42.96 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.